Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEC22B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EIF3E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DFNA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NMD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF260 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF21A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKMY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIMKLA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM184C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPA0 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on